1. Brogan Thomas, V . ECMO Specialist Training Manual. Extracorporeal Life Support Organization, Ann Arbor, Michigan. 2018.
Google Scholar2. Schmidt, M, Schellongowski, P, Patroniti, N, et al. IDEA Study Group collaborators are as follows. Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study. Am J Respir Crit Care Med. 2018;197(10):1297-1307. doi:10.1164/rccm.201708-1761OC.
Google Scholar | Crossref | Medline3. Wohlfarth, P, Ullrich, R, Staudinger, T, et al. Extracorporeal membrane oxygenation in adult patients with hematologic malignancies 104 and severe acute respiratory failure. Crit Care. 2014;18:R20.
Google Scholar | Crossref | Medline4. Gow, KW, Lao, OB, Leong, T, Fortenberry, JD. Extracorporeal life support for adults with malignancy and respiratory or cardiac failure: the extra-corporeal life support experience. Am J Surg. 2010;199(5):669-675.
Google Scholar | Crossref | Medline | ISI5. Bohman, JK, Vogt, MN, Hyder, JA. Retrospective report of contraindications to extracorporeal membrane oxygenation (ECMO) among adults with acute respiratory distress syndrome (ARDS). Heart Lung. 2016;45(3):227-231. doi:10.1016/j.hrtlng.2016.03.003.
Google Scholar | Crossref | Medline6. Munshi, L, Walkey, A, Goligher, E, Pham, T, Uleryk, EM, Fan, E. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med. 2019;7(2):163-172. doi:10.1016/S2213-2600(18)30452-1.
Google Scholar | Crossref | Medline7. Daniel, MT, Flandrin, G. Fine structure of abmormal cells in hairy cell (tricholeukocytic) leukemia, with special reference to their in vitro phagocytic capacity. Lab Invest. 1974;30(1):1-8.
Google Scholar | Medline8. Morton, LM, Wang, SS, Devesa, SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107(1):265-276. doi:10.1182/blood-2005-06-2508.
Google Scholar | Crossref | Medline | ISI9. Troussard, X, Zent, CS, Zenz, T, et al. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood. 2017;129(5):553-560. doi:10.1182/blood-2016-01-689422.
Google Scholar | Crossref | Medline10. Else, M, Dearden, CE, Matutes, E, et al. Long-term follow-up of 233 patients with hairy cell leukemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis. Br J Haematol. 2009 Jun;145(6):733-740. doi:10.1111/j.1365-2141.2009.07668.x.
Google Scholar | Crossref | Medline11. Else, M, Ruchlemer, R, Osuji, N, et al. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years. Cancer. 2005;104(11):2442-2448. doi:10.1002/cncr.21447.
Google Scholar | Crossref | Medline12. Htwe, TH, Khardori, NM. Legionnaire’s disease and immunosuppressive drugs. Infect Dis Clin North Am. 2017;31(1):29-42. doi:10.1016/j.idc.2016.10.003.
Google Scholar | Crossref | Medline13. Skopets, AA, Kornilov, IA, Afonin, ES. Importance of Extracorporeal Membrane Oxygenation (ECMO) in therapy for Legionella pneumonia in patient with hairy-cell leucosis. Innov Med Kuban. 2019;15(3):44-48. doi:10.35401/2500-0268-2019-15-3-44-48.
Google Scholar | Crossref14. Adams, DA, Jajosky, RA, Ajani, U, et al. Summary of notifiable diseases—United States, 2012. MMWR Morb Mortal Wkly Rep. 2014;61:1-121.
Google Scholar | Medline15. Mandell, LA, Wunderink, RG, Anzueto, A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72.
Google Scholar | Crossref | Medline16. Metlay, JP, Waterer, GW, Long, AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45-e67. doi:10.1164/rccm.201908-1581st.
Google Scholar | Crossref | Medline17. Kato, H, Hagihara, M, Asai, N, et al. Meta-analysis of fluoroquinolones versus macrolides for treatment of Legionella pneumonia. J Infect Chemother. 2021;27(3):424-433. doi:10.1016/j.jiac.2020.10.002.
Google Scholar | Crossref | Medline18. Sivagnanam, S, Podczervinski, S, Butler-Wu, SM, et al. Legionnaires’ disease in transplant recipients: a 15-year retrospective study in a tertiary referral center. Transpl Infect Dis. 2017;19(5). doi:10.1111/tid.12745.
Google Scholar | Crossref | Medline19. Roig, J, Rello, J. Legionnaires’ disease: a rational approach to therapy. J Antimicrob Chemother. 2003;51(5):1119-29. doi:10.1093/jac/dkg191.
Google Scholar | Crossref | Medline20. Turner, RB, Rouse, S, Elbarbry, F, et al. Azithromycin pharmacokinetics in adults with acute respiratory distress syndrome undergoing treatment with extracorporeal-membrane oxygenation. Ann Pharmacother. 2016;50(1):72-3. doi:10.1177/1060028015612105.
Google Scholar | SAGE Journals21. Gershengorn, HB, Keene, A, Dzierba, AL, Wunsch, H. The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia. Clin Infect Dis. 2015;60(11):e66-e79. doi:10.1093/cid/civ157.
Google Scholar | Crossref | Medline22. Plouffe, JF, Breiman, RF, Fields, BS, et al. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. Clin Infect Dis. 2003;37(11):1475-1480. doi:10.1086/379329.
Google Scholar | Crossref | Medline23. Noah, MA, Ramachandra, G, Hickey, MM, et al. Extracorporeal membrane oxygenation and severe acute respiratory distress secondary to Legionella: 10 year experience. ASAIO J. 2013;59(3):328-330. doi:10.1097/MAT.0b013e31829119c6.
Google Scholar | Crossref | Medline24. Bryner, B, Miskulin, J, Smith, C, et al. Extracorporeal life support for acute respiratory distress syndrome due to severe Legionella pneumonia. Perfusion. 2014;29(1):39-43. doi:10.1177/0267659113497229.
Google Scholar | SAGE Journals | ISI25. Goodman, GR, Burian, C, Koziol, JA, Saven, A. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol. 2003;21(5):891-896. doi:10.1200/JCO.2003.05.093.
Google Scholar | Crossref | Medline | ISI26. Hozalski, RM, LaPara, TM, Zhao, X, et al. Flushing of stagnant premise water systems after the covid-19 shutdown can reduce infection risk by Legionella and Mycobacterium spp. Environ Sci Technol. 2020 Dec 15;54(24):15914-15924. doi:10.1021/acs.est.0c06357.
Google Scholar | Crossref | Medline27. Palazzolo, C, Maffongelli, G, D’Abramo, A, et al. Legionella pneumonia: increased risk after COVID-19 lockdown? Italy, May to June 2020. Euro Surveill. 2020;25(30):2001372. doi:10.2807/1560-7917.ES.2020.25.30.2001372.
Google Scholar | Crossref